 NEW YORK, May 17, 2021 PRNewswire -- DarioHealth Corp. Nasdaq: DRIO, a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided a corporate and commercial update. During the first quarter, we delivered exceptional financial and operating results, driven by balanced contribution from organic growth and the acquisition of Upright Technologies, which we closed on February 2, 2021, stated Erez Raphael, Chief Executive Officer of Dario. 